IMC Chicago
ABCL icon

IMC Chicago’s AbCellera Biologics ABCL Stock Holding History

IMC Chicago’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.82M Buy
398,900
+194,300
+95% +$1.84M ﹤0.01% 2085
2026
Q2 		$1.61M Sell
204,600
-108,400
-35% -$530K ﹤0.01% 3298
2026
Q1 		$1.09M Buy
313,000
+205,000
+190% +$738K ﹤0.01% 3188
2025
Q4 		$369K Buy
108,000
+63,800
+144% +$285K ﹤0.01% 3677
2025
Q3 		$222K Buy
+44,200
New +$195K ﹤0.01% 3521

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
J.W. Cole Advisors
J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

IMC Chicago's ABCL Position: Q3 2026 in Review

IMC Chicago sold out of AbCellera Biologics (ABCL) in Q3 2026, closing a stake of 17,205 shares — an estimated $163K sold.

IMC Chicago first reported a position in ABCL in Q3 2025 and held it in 2 quarters. The position peaked at $468K in Q3 2025. 49 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • IMC Chicago reported no remaining AbCellera Biologics position as of Q3 2026 after selling out during the quarter.
  • IMC Chicago sold 17,205 AbCellera Biologics shares in Q3 2026, an estimated $163K.
  • IMC Chicago first reported a position in AbCellera Biologics in Q3 2025 and held it in 2 quarters.
  • IMC Chicago's AbCellera Biologics position peaked at $468K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.